Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
AbbVie (Japan)
h-index: 31
Total citations: 3,887
Total papers: 366
Homepage:
https://www.abbvie.co.jp
Recent papers from AbbVie (Japan)
Efficacy and Safety of Risankizumab Among Patients With Ulcerative Colitis in East Asia: A Post Hoc Analysis of Two Randomized Clinical Trials
Journal of Gastroenterology and Hepatology · 2026
Characteristics and Hospitalization Details of Patients with Advanced Parkinson’s Disease Receiving Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa: Real-World First-Year Descriptive Study from Japan
Neurology and Therapy · 2026
Economic Burden and Treatment Patterns Among Patients Diagnosed With Vitiligo in Japan: An Observational Retrospective Cohort Study
The Journal of Dermatology · 2026
Immunogenicity and safety of recombinant zoster vaccine in Japanese patients with RA receiving upadacitinib: the end Zoster-J study
Scientific Reports · 2026
Potential remote measurement of C-peptide using a minimally invasive and convenient sampling technique
Bioanalysis · 2026
Industrialization of Bayesian decision-making for proof-of-commercial-concept study designs
Journal of Biopharmaceutical Statistics · 2026
Comparison of epcoritamab, lenalidomide, and rituximab versus usual care in relapsed/refractory follicular lymphoma
OncoImmunology · 2026
Stage-specific digital health technology biomarkers enhance diagnostic and early progression detection in Parkinson’s disease
Frontiers in Neurology · 2026
Dilution displacement enabled measurement of total ligand levels in the presence of an anti-ligand antibody using LBA
Bioanalysis · 2026
Qualitative Study to Characterize the Patient-reported Experience of Menstrual Migraine (P8-15.001)
Neurology · 2026
Patient Treatment Satisfaction with OnabotulinumtoxinA Versus Topiramate for Chronic Migraine (P1-15.009)
Neurology · 2026
Hybrid Concept Elicitation and Cognitive Debriefing of Patient-reported Outcome Measures in Patients with Menstrual Migraine (P8-15.003)
Neurology · 2026
Comparative Efficacy, Safety, and Tolerability of Atogepant and Erenumab: Indirect Treatment Comparison of the TEMPLE and HER-MES Head-to-head Trials (P10-15.002)
Neurology · 2026
Muscle Proteins in Plasma are Increased in Patients with Amyotrophic Lateral Sclerosis (ALS) (P8-7.005)
Neurology · 2026
Real-world Acute Treatment Optimization for Migraine with Ubrogepant: Results from the COURAGE II Study (P8-15.015)
Neurology · 2026
High-throughput Proteomics in CSF and Plasma from ALS Patients Identifies Novel Biomarkers Related to Muscle Structure and Function (S32.005)
Neurology · 2026
Hydrogenation Kinetics Study: Precise Control of C=C Bonds in Polyisoprene (PI)-Containing Block Copolymers via Diimide Hydrogenation
ACS Applied Polymer Materials · 2026
A phase 2 randomized study comparing telisotuzumab adizutecan monotherapy with standard of care in patients with post-adjuvant circulating tumor DNA–positive colorectal cancer.
Journal of Clinical Oncology · 2026
Circulating CTHRC1 levels are associated with IPF disease severity and survival
Thorax · 2026
Subcutaneous foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson’s disease (aPD): societal cost impact analysis for the UK, France, Germany, Spain, and Canada
Journal of Medical Economics · 2026